Costa Rica vs Portugal: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Costa Rica
98.0%
in 2025
Portugal
98.0%
in 2025
Costa Rica rank
11th
Portugal rank
11th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Costa Rica
- Portugal
How they compare
Costa Rica currently reports 98.0% against 98.0% in Portugal, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Portugal ahead.
Costa Rica ranks 11th and Portugal ranks 11th of 194 countries.
Across the 3 decades both report, Costa Rica averaged higher in 2 and Portugal in 1.
Head to head by decade
| Decade | Costa Rica | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.0% | 0.0% | 24.0% | Costa Rica |
| 2010s | 90.2% | 36.5% | 53.7% | Costa Rica |
| 2020s | 94.8% | 98.0% | 3.2% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Costa Rica or Portugal?
- Costa Rica, at 98.0% against 98.0% in Portugal as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Costa Rica and Portugal?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Portugal?
- 18 years are reported by both, from 2008 to 2025.
- How do Costa Rica and Portugal rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Costa Rica ranks 11th and Portugal ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.